Announcement: Aurelia Bioscience has been acquired by Charnwood Molecular.

Share this

CEOs, policymakers and thought leaders from around the world will discuss what’s new in areas such as drug discovery, clinical trials and market access enabling delegates to stay on top of the latest trends and innovations in life sciences.

Lorraine will be available during the networking sessions to discuss how Charnwood Molecular can support companies with their pre-clinical drug discovery projects.

You can find out more about out highly experienced team of scientists, covering disciplines from biology and DMPK / ADME through to computational, medicinal and process research chemistry, act together seamlessly to provide the right environment for an integrated solution to drug discovery.

To join this event and connect with Lorraine click here.